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Ventilator-associated pneumonia is one of the critical complications identified 
by a chest x-ray (CXR).  However, there is a controversy about the use of CXRs.  
Overuse of the CXR has also identified concern among the ICU patient population.  
The purpose of this evidenced-based practice project was to determine if there were 
differences in patient outcomes when receiving daily routine CXRs as compared to 
clinically-indicated CXRs.   Patient outcomes measured were:  ICU length of stay, 
complications while on the ventilator and ICU mortality, number of ventilator days, 
diagnostic efficacy, therapeutic efficacy, costs, and radiation exposure    
 The author identified 30 articles in the search process.  These articles were 
reduced to 15 after identifying duplicates and applying the inclusion and exclusion 
criteria.  Analysis was performed using an evidence table according to the process 
developed by Melynk and Fineout-Overholt.  Analysis of the research findings from 
15 studies that included randomized clinical trials, observational studies, cohort 
study, cluster randomized crossover study, meta-analysis, blind-peer reviews, and 
expert opinions revealed moderate support for the use of clinically-indicated CXRs 
for patients in the ICU on a ventilator.  Following the analysis of the literature a -
retrospective chart audit was performed to determine if practice patterns in my 
institution matched the recommendations in the literature.   
A sample of 60 patient records was drawn from 234 records of patients who 




The sample was equally divided between men and women who were primarily 
Caucasian with a mean age of 59.3.  The most common admitting diagnoses were:   
ventilator dependent respiratory failure, sepsis, and chronic obstructive pulmonary 
disease.  Patient outcomes were measured using a researcher developed chart audit tool.  
Analysis of the chart audit data revealed that in a three month period only one patient 
was treated with the clinically-indicated CXR regimen.  The recommendation is that the 
professional practice group should begin discussion regarding the development of a 
policy and procedure in order to differentiate between patients who need daily routine 
versus clinically-indicated CXRs for improved outcomes and adherence to the current 
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CHAPTER 1- INTRODUCTION 
Eighty-six percent of nosocomial pneumonias are associated with mechanical 
ventilation and are termed ventilator-associated pneumonia (VAP).  According to the 
Center for Disease Control and Prevention (CDC) (2014) more than 300, 000 patients 
receive mechanical ventilation in the United States every year.  These patients are at high 
risk for complication and poor outcomes, including death (CDC, 2014).  Complications 
of VAP can lead to longer stays in the Intensive Care Unit (ICU) and hospital, longer 
duration of mechanical ventilation, increased risk of disability and death, and increased 
healthcare costs (CDC, 2014).  Mortality in patients with acute lung injury on mechanical 
ventilation has been estimated to range from 24% in persons 15-19 years of age up to 
60% for patients 85 years and older (CDC, 2014).  
The National Healthcare Safety Network (NHSN) is the nation’s most widely 
used healthcare-associated infection (HAI) tracking system (CDC, 2014).  CDC (2014) 
further reports that NHSN provides facilities, states, regions, and the nation with data 
needed to identify problem areas, measure progress of prevention efforts, and ultimately 
eliminate HAIs.  The Centers for Medicaid and Medicare (CMS) has partnered with the 
NHSN in an effort to report and track such a hospital inpatient quality reporting program.  
For the year 2010, NHSN facilities reported more than 3,525 VAPs, and the VAP 
incidence for various types of hospital units ranged from 0.0-5.8 per 1,000 ventilator days 
(CDC, 2014).  
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Chest Radiographs (CXR) are a common intervention used in the ICU to 
visualize and diagnose VAP.  However, there has always been a concern about the 
overuse of diagnostic studies such as the CXR for patients who are mechanically 
ventilated in the ICU setting secondary to various adverse outcomes including costs 
(Oba & Zaza, 2010).  There has also been a concern regarding the dose of radiation 
that is associated with the overuse of CXRs (Oba & Zaza, 2010).  This problem is of 
special concern in the ICU because current standard practice is for patients to receive 
a CXR routinely on a daily basis (Prat, 2009).   
The purpose of this evidenced-based practice project is to compare daily 
routine CXR versus clinically-indicated CXR in preventing VAP in adult ICU 
patients’ on ventilators.  The goal of this project is to determine if daily routine CXRs 
produce better patient outcomes than clinically-indicated CXRs.  Chapter 1 presents a 
description of the problem, scope of the problem, documented need for analysis of 
current practice guideline (i.e. documented need for change), discussion of practice 
innovation (i.e. best practice to address the problem), statement of the problem/ 
purpose, and summary. 
Description of the Problem 
Ventilator-associated pneumonia is defined as an airway infection that 
develops more than forty-eight hours after a patient is intubated (Ibrahim, Hill, 
Fraser, & Kollef, 2001). Ventilator-associated pneumonia arises when there is 
bacterial invasion of the pulmonary parenchyma in a patient receiving mechanical 
ventilation (Coffin, et al., 2008).   
There are common diagnostic tests such as a CXR that are performed in acute 
care settings to help visualize and manage a patient’s pulmonary status.   
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Patients that require intubation and mechanical ventilation in the ICU are especially 
in need of diagnostic test such as the CXR.  The CXR has allowed intensivist 
healthcare providers to directly assess endotracheal tube positioning for adequate 
oxygenation and ventilation via the pulmonary system (Siela, 2002).  A daily CXR 
may also provide a non-invasive internal visualization of the pulmonary tree 
including the trachea, right and left lung fields, cardiac silhouette, mediastinum, 
diaphragm, pulmonary arteries, bony structures, and line placement (Siela, 2002).   
Ventilator-associated pneumonia is one of the critical complications identified 
by a CXR.  This evidenced-based practice project will focus on identifying 
assessment variables and or outcomes that determine clinical significance of daily 
routine CXRs, and to also identify the best practices for prevention of VAP with use 
of the CXR. 
The clinical characteristics that lead to VAP include: inoculation of the 
formerly sterile lower respiratory tract (typically arising from aspiration of 
secretions), colonization of the aero-digestive tract, or use of contaminated equipment 
or prescribed medications (Coffin, et al., 2008).  Risk factors for VAP also affect the 
incidence of ventilator-associated events (VAE) in the adult medical ICU patient 
population.  Therefore complications of VAP are termed (VAEs).  See Figure 1.1 








Figure 1.1.VAP Pathogenesis Factors.  Reproduced with permission from Zolfaghari 
and Wyncoll   















Coffin et al. (2008) reported risk factors for VAP to include prolonged 
intubation, enteral feeding, witnessed aspiration, paralytic agents, underlying illness, 
and extremes of age such as the older adult.  Other risk factors of concern identified 
for VAP risk factors included: overall health status and comorbid health conditions.  
Pre-existing conditions that increase the risk for VAP in intubated and mechanically 
ventilated patients include smoking and various microbial pathogens including 
pseudomonas species and other highly resistant gram-negative bacilli, staphylococci, 
enterobacteriaceae, streptococci, and haemophilus species (Park, 2005).  Antibiotic-
resistant pathogens such as pseudomonas and acinetobacter species and methicillin-
resistant strains of staphylococcus aureus are much more common after prior 
antibiotic treatment or prolonged hospitalization or mechanical ventilation, and when 
other risk factors are present (Park, 2005). The bacterial pathogens responsible for 
VAP also vary depending on patient characteristics and in certain clinical 
circumstances, such as in acute respiratory distress syndrome (ARDS) or following 
tracheotomy, traumatic injuries or burns (Park, 2005). 
Another variable contributing to the debate about daily routine versus 
clinically-indicated CXRs is radiation overexposure.  Radiation overexposure not 
only affects the patient but also staff members in the surrounding areas.  All may be 
inadvertently exposed to dosages of overdoses of radiation (Prat, 2009). 
Scope of the Problem 
Pneumonia is the second-most-common hospital-acquired infection (HAI) in 
the United States accounting for 17.8% of all hospital-acquired infections and 40,000 
to 70,000 deaths per year (Iregui & Kollef, 2001).  Healthcare-associated pneumonia 
(HAP) and VAP are the second-most-common cause of nosocomial infection overall 
(Rostein et al., 2008).   
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Also, both HAP and VAP are the most common causes documented in the intensive 
care unit (Rotstein et al., 2008).   
In the adult ICU patient population, the incidence of VAP for various types of 
hospital units ranged from 0.0-5.8 per 1,000 ventilator days (CDC, 2014).  Ventilator-
associated pneumonia, sepsis, ARDS, pulmonary embolism, barotrauma, and 
pulmonary edema are among the complications that can occur in patients receiving 
mechanical ventilation (CDC, 2014).  Such complications can lead to longer duration 
of mechanical ventilation, longer stays in the ICU and hospital, increased healthcare 
costs, and increased risk of disability and death.   
In the past 20 years, the overall incidence of HAIs in the United States has 
increased by 36% (Stone, 2009).  Annually, approximately 2 million patients suffer 
from a HAI and an estimated 90,000 of these patients die (Stone, 2009).  This statistic 
ranks HAI as the fifth leading cause of death in acute care hospitals settings (Stone, 
2009).  CDC (2014) estimated that more than 300,000 patients receive mechanical 
ventilation every year.  Given this staggering statistic referencing VAP mortality, the 
need for better source control of this clinical phenomenon is critically important.   
The Center for Medicaid and Medicare Services (CMS) outlined various 
indicators for quality healthcare outcomes for patients’ in acute care facilities.  In 
addition, and in the interest of promoting high-quality, patient-centered care and 
accountability CMS (2013) and the Hospital Quality Alliance (HQA) began publicly 
reporting VAP in June 2008.  Publicly reporting these measures increases the 
transparency of hospital care, provides useful information for consumers choosing 
care, and assists hospitals in their quality improvement efforts (CMS, 2013).   
Ventilator-acquired pneumonia is such a prevalent and important issue that now CMS 
and HQA are tracking and reporting these events for consumers.   
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The direct relationship that affects the consumer (i.e. patient) is that of costs.  
Therefore, another important aspect associated with scope of the problem included 
identifying the effects of costs associated with ventilated patients with VAP.  Factors 
influenced by VAP included addressing the costs of the daily CXR versus clinically-
indicated, costs associated with antibiotic therapy, and average costs of ventilated 
patients with VAP versus those who do not have VAP. 
Analysis of Current Practice Guidelines 
Documented Need for Change 
Ganapathy et al. (2012) argued that many providers in the intensive care 
setting are concerned about the severity of cardiopulmonary illness and complexity of 
medical intervention.  One of the biggest concerns of providers with the consideration 
of transition to clinically-indicated CXR included risk of patient complications and 
the risk for mortality in the ICU.   
 A common mortality indicator scale utilized within the ICU setting is that of the 
Acute Physiology and Chronic Health Evaluation (APACHE II) score (Kager et al., 
2010).  This scale can be used to predict a patients’ risk for mortality given the 
patient’s chronic medical history, admission diagnosis, and current clinical status.   
Ganapathy et al. (2012) stated that the frequency of complications such as device 
malpositioning, pneumothoraces, and cardiac arrthymias have led to recommended 
daily routine CXRs for all patients with acute cardiopulmonary problems or receiving 
mechanical ventilation.  Ganapathy et al. (2012) outlined the advantage of daily 
routine CXR to include prompt detection of complications, and thus, earlier treatment 
of clinically unsuspected abnormalities, documentation of disease progression or 
response to therapy, and educational value for trainees.   
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The use of daily routine versus clinically-indicated CXRs to prevent ventilator 
associated events such as VAP in ICU patients prompted further investigation by this 
author.  Furthermore, CDC (2013) evidence suggested that CXR findings alone do not 
accurately identify VAP.  CDC (2013) further stated that the subjectivity and variability 
inherent in CXR technique, interpretation, and reporting make chest imaging ill-suited 
for inclusion in a definition algorithm to be used for the potential purposes of public 
reporting, inter-facility comparisons, and pay-for-performance programs. 
In contrast, there were various pieces of evidence that supported forgoing the 
daily routine CXR approach and focusing on a clinically-indicated CXR.   
First, Prat (2009) stated that radiology departments likely have little incentive to 
abandon the practice of daily routine CXRs as each radiograph taken generates revenue 
for the radiology department and the radiologist interpreting it.  Second, there is a 
strongly engrained practice culture of the daily CXR in the ICU (Oba and ZaZa, 2010).  
Critical care providers are ordering daily CXR as a precaution to assure that potential 
complications are not missed.  However, an abundance of authors argued that outcomes 
are the equitable for patients who receive daily routine CXRs or clinically-indicated 
CXRs (Clec “h et al., 2008; Fishman & Primack, 2005;  Ganapathy, et al., 2012; Graat, 
et al., 2005; Graat, et al., 2006; Gratt et al., 2007; Kager et al., 2010; Krivopal et al., 
2003; Kroner et al.,2008; Hejblum et al., 2009; Hendriksen,2007; Magill, et al., 2013; 
Oba & ZaZa, 2010;  Prat, 2009; Siela, 2002; and Siegel, 2009). 
Discussion of Practice Innovation/ Best Practice to Address the Problem 
Intensivist health care providers have remained divided over this best practice 
clinical quandary for many years.  There is evidence to support utilization of 
diagnostic tests to guide the clinician’s interventions and management of intubated 
and mechanically ventilated patients.   
9 
 
This evidenced-based practice project aims to evaluate both daily routine and 
clinically-indicated CXR best practice in the prevention of VAP for adult ICU 
patients on ventilators. 
Statement of the Problem/ Purpose 
The purpose of this evidenced-based practice project is to determine if daily 
routine CXRs produce better patient outcomes than clinically-indicated CXRs.  The 
evidence-based practice question is: In the adult ICU patient on the ventilator, is there 
a difference between daily routine CXRs and clinically-indicated CXRs on patient 
outcomes of ICU length of stay, complications while on the ventilator, ICU mortality, 
and number of ventilator days, costs, and radiation exposure?  Table 1.1 contains the 
definitions of population, intervention, comparison, and outcomes as defined by 












Table 1.1PICOT Definitions 
Population of Interest       Adult ICU Intubated and 
          Mechanically Ventilated  
          Patient’s 
         Intervention or Issue 
            of Interest 
          Daily Routine CXRs 
 Comparison of Interest           Clinically-Indicated CXRs 
         Outcome Expected           ICU Length of Stay 
          Complication(s) while on  
          the Ventilator & ICU  
          Mortality 
          Number of Ventilator Days 
          Diagnostic Efficacy 
          Therapeutic Efficacy 
          Costs 
          Radiation Exposure 
         Time for the Intervention  
         to Achieve the Outcome 
        Time During Hospitalization  
        of The Patient 
 
Definitions 
Comparison of Interest:  Clinically-indicated CXR in the intubated and mechanically 
ventilated patient.   
Diagnostic Efficacy:  The number of CXRs with new or progressive major predefined 
findings divided by the total number of CXRs obtained. 
Intervention or Issue of Interest:  Daily routine CXR in the intubated and 
mechanically ventilated patient. 
ICU:  Intensive Care Unit  
Outcome Expected:  Expected outcomes to be evaluated for adult intubated and 
mechanically ventilated patients’ include:  ICU length of stay, complications while on 
the ventilator & ICU mortality, number of ventilator days, diagnostic efficacy, 






ICU length of stay:   The total number of patient days in the intensive care unit. 
Complications while on the ventilator and ICU mortality:  Ventilator complications 
can lead to longer duration of ICU stay, increased risk of disability and death, tube 
dislodgement, and increased healthcare costs. 
Number of ventilator days:  The total number of days the patient is mechanically 
ventilated. 
Diagnostic efficacy:  Is used as an indicator of the value of the CXR to assist in the 
development of a diagnosis by a clinician.  Diagnostic efficacy includes the total 
number of CXRs with new or progressive predefined findings divided by the total 
number of CXRs obtained (Kager et al. (2010). 
Therapeutic efficacy: Is any intervention that includes changes in antibiotic therapy,  
bronchoscopy, administration or change in diuretic therapy, thoracentesis, and 
repositioning of endotracheal tube and lines (Clec ‘h et al (2008). 
Costs:  The total monetary amount billed for each ICU patient CXR.  
Radiation exposure:  The total amount of radiation associated with CXR. 
Population of Interest:  Adult ICU intubated and mechanically ventilated patient > 18 
years of age.  The gender includes male or female patients’ requiring continuous 
ventilation for a specific health problem. 
Time for intervention to achieve the outcome:  Includes the amount of time the 
patient requires for the hospitalization. 
Mechanical Ventilation:  A form of continuous ventilation for extrinsic oxygenation 
as measured by breaths per minute, volume in CC of breath per breath, and percent of 




The next step in the evidenced-based practice process is the literature search 
to obtain the evidence to answer the evidenced-based practice question.  The evidence 
will be organized using an evidence table.  This process is explained in detail in 
chapter II.  Also, the evidence will be analyzed by the author.    
In conclusion, the goal of this evidenced-based practice project is to determine 
the best method for preventing VAP in mechanically ventilated patients regarding the 
utility of daily routine versus clinically-indicated CXRs in patients on ventilators.  
Complications such as ventilator-acquired events (VAE) and subsequent VAP can be 
fatal and are of major concern for the adult ICU intubated and mechanically 
ventilated patient.  This evidenced-based practice projects aim is to compare, contrast 
and determine the best practice for use of daily routine versus clinically-indicated 
CXRs for preventing VAP in adult ICU patients on ventilators.  Chapter II will 




CHAPTER II - REVIEW OF THE LITERATURE 
 The evidenced-based practice project began with the development of a clinical 
question using the PICOT format as defined by Melnyk & Fineout-Overholt (2011).  
Chapter II presents the search process, evidence table, analysis of the literature, and 
synthesis of the evidence.  The purpose of this evidenced-based practice project is to 
determine if daily routine CXRs produce better patient outcomes than clinically-
indicated CXRs.  The evidence-based practice question is: In the adult ICU patient on 
the ventilator, is there a difference between daily routine CXRs and clinically-
indicated CXRs on patient outcomes of ICU length of stay, complications while on 
the ventilator, ICU mortality, number of ventilator days, costs, and radiation 
exposure? 
Search Process 
The search process began with seven electronic databases appropriate for this 
project.  The databases were CINAHL, University of South Carolina (USC) 
Powersearch, MEDLINE OVID, PUBMED, Web of Science, Cochrane Database, 
and National Guidelines Clearinghouse. The search used the concepts from the 
PICOT definitions: critical care, daily routine, clinically-indicated, CXR, intensive 
care unit, patient outcomes, financial impact, mechanical ventilation, diagnostic 
efficacy, therapeutic efficacy, and radiation exposure.  The search process used an 
expanded version of the PICOT definitions to find the broadest possible literature that 
might contain information pertinent to this evidenced-based practice question.  These 
terms included:  intensivist, adverse effect, and patient safety.
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The author identified a number of selection criteria in order to determine 
literature that would answer the evidenced-based practice question.  All articles were 
in English and within the last 10 years, 2003-2013.  Articles were excluded if they 
pertained to children or did not meet the PICOT definitions.  The next step in the 
search process involved a systematic search to identify the best evidence to answer 
the evidence-based practice question.  The search revealed a combination of thirty 
randomized clinical trial articles, observational studies, cohort study, cluster 
randomized crossover study, meta-analysis, blind-peer reviews, and expert opinion 
articles.  Patient outcomes measured were:  ICU length of stay, complications while 
on the ventilator and ICU mortality, number of ventilator days, diagnostic efficacy, 
therapeutic efficacy, costs, and radiation exposure.  CINAHL produced the most 
relevant articles.  The articles were reduced from 30 to 15 by eliminating duplicates 
and applying the inclusion and exclusion criteria.     
Analysis of the Evidence 
The first step in analysis was to organize and analyze the evidence.  The 
evidence was organized using an evidence table described by Melnyk & Fineout-
Overholt (Appendix A).  The categories on the evidence table were reference, quality 
rating, method, threats to validity / reliability, findings, and conclusion.  They 
proposed a hierarchy of evidence rating system that rated research quality from I-VII 
with I being the highest quality of evidence and VII being the poorest quality of 
evidence.  The articles were placed in the evidence table in descending order of 
quality with Level I studies listed first and Level VII studies listed last. Table 2.1 




 Table 2.1 Hierarchy of Evidence 
Level I Evidence from a systematic 
review or meta-analysis of all 
relevant randomized clinical trials 
(RCT) 
Level II Evidence obtained from well-
designed (RCT) 
Level III Evidence obtained from well-
designed controlled trials without 
randomization 
Level IV Evidence from well-designed 
case-control and cohort studies 
Level V Evidence from systematic reviews 
of descriptive and qualitative 
studies 
Level VI Evidence from single descriptive 
or qualitative studies 
Level VII Evidence from the opinion of 
authorities and /or reports of 
expert committees 
Melnyk & Fineout-Overholt (2011).  Evidenced-Based Practice in Nursing &  
   Healthcare. A Guide to Best Practice. 
 
The second step in organizing the articles was to identify specific outcomes measured 
in the research studies.  The outcomes measured included ICU length of stay, 
ventilator complications and ICU mortality, number of ventilator days, diagnostic 
efficacy, therapeutic efficacy, costs, and radiation overexposure.  The analysis began 
by focusing on patient outcomes from studies that compared daily routine to 







ICU Length of Stay  
Four studies, one level I, one level II, and two levels III, compared daily 
routine CXR with clinically-indicated CXR on length of stay in ICU for patients on 
mechanical ventilation.  All studies found that elimination of daily routine CXRs did 
not alter length of stay in the ICU.   

























-Hejblum et al., 
(2009) 






    
 
Oba & ZaZa (2010) conducted a meta-analysis which included eight studies with 
a total of 7078 identified patients.  This study aimed to determine whether abandoning 
daily routine CXR versus utilization of clinically-indicated CXR would affect patient 
outcomes such as ICU length of stay.  This study was rated a level I.  Of the 7078 adult 
patients, 3429 underwent daily routine CXRs and 3649 had the clinically-indicated 
CXRs.  The authors concluded that there was no statistically significant difference in ICU 
length of stay with the daily routine versus clinically-indicated CXR group.  The 
weighted mean difference was 0.19 days (95% confidence interval: -0.13, 0.51; p = 0.25).  
Ultimately, the researchers found that daily routine CXR could safely be eliminated 
without compromising patient care or increasing length of stay in the ICU. 
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Hendrikse (2007) conducted a prospective observational study in an adult 10-
bed mixed medical surgical ICU of a teaching hospital.  This study was a rated a level 
III.  He investigated the effects of eliminating daily routine CXR on ICU length of 
stay.  The sample population included data on 1780 daily routine CXRs in 559 
hospital admissions.  The study period lasted 1-year and was divided into two parts.     
The first part of the study focused on other outcomes variables.  However the 
second part of the study focused on ICU length of stay (LOS).  The second part of the 
study revealed 433 CXRs that were obtained in 274 admissions.  Of the 559 hospital 
admissions 486 patients were evaluated.  The researcher learned that of the 79 (4.4%) 
daily routine CXRs versus the 138 (15.2%) of clinically-indicated CXRs only 33 
(1.9%) of the daily routine CXRs versus the 162 (17.9%) clinically-indicated CXRs 
led to a change in ICU length of stay.   
The author defined length of stay (LOS) into three different categories.  These 
three categories were:  short stay (1-2 days), intermediate stay (3-14 days), and long 
stay (>14 days).  The sample population included 589 patients.  According to the 
author of the 589 patients 349 (61%) had a 1-2 days ICU stay, 179 (32%) had a 3-14 
day stay, and 39 (8%) had a greater than or equal to 15 day stay (p-value = <0.001).  
In conclusion, there was found to be no change in the ICU length of stay between 
patients who had daily versus clinically-indicated CXRs to prevent VAP.   
 Hejblum et al. (2009) conducted a cluster-randomized, open-label crossover 
study where 21 intensive care units from 18 hospitals in France searched to find out if 
the use of a daily routine or clinically-indicated strategy for CXR was more 
beneficial.  This study was rated level II.   
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The studies included 967 patients but of those 118 were excluded because they had 
been receiving mechanical ventilation for less than 2 days.  Overall, 424 patients had 
4607 daily routine CXRs and 425 patients had 3148 clinically-indicated CXRs.  The 
age range for the daily routine CXR group was 51-74 with a mean age of 61, and the 
clinically-indicated CXR group ages ranged from 49-74 with a mean of age 63.   
The reasons for mechanical ventilation for both sample groups included thoracic 
diseases such as:  acute respiratory distress syndrome (ARDS) or acute lung injury 
(ALI), pneumonia, acute on chronic respiratory insufficiency, cardiogenic edema, 
asthma, coma, shock, and postoperative care.   
The results of the study supported clinically-indicated CXRs versus daily routine 
were safe and did not reduce patient quality of care.  The study also demonstrated that 
there were no statistically significant differences between patient lengths of stay to 
improve with clinically-indicated (13.21%) versus daily routine (13.96%) CXRs for 
mechanically ventilated patients (p < 0.28). 
Gratt et al. (2007) performed a 5-month prospective, nonrandomized, 
controlled study with patients in a 28-bed ICU.  The study was divided into two 
phases.  This study was rated a level III.  A total of 3894 CXRs were obtained from 
754 patients in phase one which included 2457 daily routine CXRs and 1437 
clinically-indicated CXRs (Gratt, 2007).  A total of 1267 CXRs were obtained from 
622 patients in phase two.  The study involved 2,457 participants who received daily 
routine CXR and 1,437 participants who received clinically-indicated CXR (Gratt, 
2007).  In phase 1, patient outcomes were measured for 5 months before the CXR 
intervention was implemented.   
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Phase 2 began one month after phase 1 concluded.  In phase 2, participants received 
either daily routine CXRs or clinically-indicated CXRs as determined by their 
healthcare providers over 5 months.   
The researchers found that not only did the number of CXRs per patient per day 
decline from 1.1 days +/-0.3days to 0.6 days+/-0.4 days (p<0.05), but also there was 
no statistically significant difference in the phase one versus phase two participants 
on length of stay in ICU.  Overall, daily routine CXRs did not reduce length of ICU 
stay as an effective patient management in the prevention of VAP.  
Complication While on the Ventilator and ICU Mortality 
Three studies, two level I and one level III, compared daily routine CXR with 
clinically-indicated CXR on complications and ICU mortality for patients on 
mechanical ventilation.  All studies found that elimination of daily routine CXRs did 
not change complication rate or ICU mortality.   
Table 2.3 Quality Level of the Articles Measuring Complications While on the 
Ventilator and ICU Mortality 
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 Ganapathy, Adhikari, Spiegelman, and Scales (2012) presented a meta-analysis 
on the necessity of routine CXR in the intensive care unit.  This study was 
categorized at the highest rating of I.  The purpose of this meta-analysis was to review 
the utility of one of the most frequent radiological diagnostic tests performed in the 
intensive care setting.  The meta-analysis determined potential patient risks and 
complications for mechanically ventilated patients.   
Ganapathy et al. (2012) argued that many providers in the intensive care setting are 
concerned about the severity of cardiopulmonary illness and complexity of medical 
intervention.  One of the biggest concerns of providers included mechanically 
ventilated patient complications and the risk for mortality in the ICU.   
 Ganapathy et al. (2012) stated that the frequency of complications such as 
device malpositioning, pneumothoraces, and cardiac arrthymias have led to 
recommended daily routine CXRs for all patients with acute cardiopulmonary 
problems or receiving mechanical ventilation.  Ganapathy et al., (2012) outlined the 
advantage of daily routine CXR to include prompt detection of complications and 
thus earlier treatment of clinically unsuspected abnormalities, documentation of 
disease progression or response to therapy, and educational value for trainees. 
 In this meta-analysis, nine studies were included for a total of 39,358 CXRs 
conducted on 9,611 patients from the United States, Canada, France, The Netherlands 
and Germany (Ganapathy et al., 2012).   Pooled data showed that the primary 
outcome of ICU mortality did not demonstrate a statistical significance between 
clinically-indicated and daily routine CXR groups on ventilator complications and 
ICU mortality (95% CI 0.84 to1.28), (p value = 0.72).   
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Results were also similar between groups for hospital mortality (95% CI 0.68 to 
1.41), (p value = 0.91).   Ganapathy et al. (2012) concluded that the meta-analysis did 
not detect any statistically significant differences in mortality between daily routine 
CXRs and clinically-indicated CXRs.   
 Oba & ZaZa (2010) conducted a meta-analysis which included eight studies 
with a total of 7078 patients.  This study aimed to determine whether abandoning 
daily routine CXR versus utilization of clinically-indicated CXR would affect patient 
outcomes such as ICU mortality.  This study was rated a level I.  Of the 7078 patients 
3429 underwent daily routine CXRs and 3649 had the clinically-indicated CXRs.  
The study found that there was no statistically significant difference in ICU mortality 
in the daily routine versus clinically-indicated CXR group pooled analysis of 0.92 
odds ratio (OR) with a 95%  (confidence interval: 0.76, 1.11; (p =0.4) for this 
outcome.  The study found that elimination of daily routine CXR did not affect ICU 
mortality. 
 Kager, et al. (2010) conducted a prospective nonrandomized controlled study 
regarding the value of routinely obtained radiographs for a medical-surgical ICU.  
The study was rated a level III.  The study took place over a 10 month period in a 28-
bed mixed medical-surgical ICU.  The sample population included a total of 1081 
patients of which 854 were daily routine and 227 were clinically-indicated.  The study 
found that complications such as loss of orotracheal tubes or indwelling catheters may 
cause hemodynamic deterioration and in fact may induce more pain and anxiety of 




Number of Ventilator Days 
 There were three level II and one level III study that compared routine daily CXR 
and clinically-indicated CXR on days of mechanical ventilator.  In patients on 
ventilators, both of these studies had no statistically significant difference between 
groups on days of mechanical ventilation.  One level III study drew the same 
conclusion.  The researcher cautioned that the sample was too small to conclude 
anything.   
However, the finding is consistent with the two level II studies.  All studies found that 
elimination of daily routine CXRs did not change number of ventilator days.   
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Clec’ h, et al. (2008) conducted a level II randomized controlled trial comparing 
daily routine CXR with clinically-indicated CXR on days of mechanical ventilation.  
The randomized study population included 165 patients who were mechanically 
ventilated for 48 hours or more.  The sample included 372 patients.  191 patients were 
deemed eligible and the remaining 26 were excluded because of: length of mechanical 
ventilator days less than 48 hours, reintubation, therapeutic limitation and tracheostomy 
(Clec’h, et al. 2008).   
After meeting the selection criteria 165 patients were selected to participate in the 
study.  Eighty-four patients were assigned to the daily routine CXR group and 81 were 
assigned to the clinically-indicated CXR group.  The number of days of mechanical 
ventilation of those receiving daily routine CXRs was approximately 9.7 days versus 9.8 
days for those patients in the clinically-indicated CXR group.   
Clec ‘h et al. (2008) found no statistically significant difference in the number of 
ventilator days when comparing daily routine versus clinically-indicated CXR (p = 0.94).  
The author recommended that a rational use of CXRs be based on clinical judgment and 
evaluation by the clinical provider.   
 Krivopal et al. (2003) performed a level II randomized observational study 
comparing daily routine CXR and clinically-indicated CXR on length of mechanical 
ventilation.  There were 94 participants who were hospitalized in medical ICU.  94 
patients were evaluated over a 10-month period.  A total of 293 CXRs were obtained 
from 43 patients in the routine arm of the study (Krivopal et al. (2003).  These included 
200 daily routine CXRs and 93 clinically-indicated CXRs.  
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In the non-routine arm of the study there were 226 CXRs acquired from 51 patients 
(Krivopal et al. (2003).  The mean age for the routine arm was 64.3 years and non-
routine arm 61.5 years of age (Krivopal et al. (2003).  Major co-morbidities for the 
routine arm group included:  cardiac (35), pulmonary (13), renal (7), endocrine (14), 
and neurologic (11) (Krivopal et al. (2003).  Major co-morbidities for the non-routine 
arm included:  cardiac (35), pulmonary (15), renal (9), endocrine (13), and neurologic 
(11) (Krivopal et al. (2003).  The mean time on the ventilator for the daily routine 
CXR group was 7.93 days +/-5.64 days in comparison to 6.76 days +/-4.03 days of 
the clinically-indicated CXR group.  The difference was not statistically significant (p 
=0.2606).  The researchers concluded that it would be more prudent to use clinically-
indicated CXRs as this approach was equitable in outcomes on number of ventilator 
days (Krivopal et al., 2003). 
Hejblum et al. (2009) conducted a cluster-randomized, open-label crossover 
study where 21 intensive care units from 18 hospitals in France searched to find out if 
the use of a daily routine or clinically-indicated strategy for CXRs was more 
beneficial.  The study was rated a level II.  The study included 967 patients but of 
those 118 was excluded because they had been receiving mechanical ventilation for 
less than 2 days.  Overall, 424 patients had 4607 daily routine CXRs and 425 patients 
had 3148 clinically-indicated CXRs.  The age range for the daily routine CXR group 
was ages 51-74 with a mean of 61, and the clinically-indicated CXR group ages 
ranged from 49-74 with a mean of 63.  The reasons for mechanical ventilation for 
both sample groups included thoracic diseases such as:  acute respiratory distress 
syndrome (ARDS) or acute lung injury (ALI), pneumonia, acute on chronic 
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respiratory insufficiency, cardiogenic edema, asthma, coma, shock, and postoperative 
care.  The study demonstrated that patients with clinically-indicated CXRs in the ICU 
versus daily routine CXRs were found to have fewer days of mechanical ventilation 
(p value = 0.009). 
In addition, Graat et al. (2006) performed a prospective observational study in a 
28-bed, mixed medical-surgical ICU of a university hospital.  This study was rated a 
level III.  The purpose of the study was to determine if daily routine CXRs could be 
replaced with clinically-indicated CXR.  The study period was over 5 month duration, 
and 2,457 daily routine CXRs were completed in754 consecutive ICU patients.  
Demographic data for the 754 patients included an average age of 59.8 years, and the 
reason for admission to the ICU included:  large atelectasis (>2 lobes), large 
infiltrates (>1 lobe), severe pulmonary congestion, severe pleural effusion, 
pneumothorax/pneumomediastinum, and malposition of the orotracheal tube.   
The researchers found that days of mechanical ventilation was not influenced by the 
elimination of daily routine CXRs.  The data revealed that of 754 patients a total of 
3,894 CXRs were completed.   
Of these 3,894 CXRs 2,457 were categorized as daily routine (63.1%) and the 
remaining as clinically-indicated (Gratt et al. (2006).  Gratt et al. (2006) went on to 
show that the sensitivity and specificity of the clinicians in predicting changes on 
daily routine CXR wer 2.1% (3/145) and 99.3% (2296/2312) respectively.  In 
addition, Gratt et al. (2006) stated that “although sensitivity improved with those 
CXRs that were categorized as clinically-indicated CXRs (21% [8/38]), specificity 
dropped to 59% (167/283).  However, the study population was small and; therefore, 
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the researchers expressed caution about drawing any conclusions.  Gratt et al. (2006) 
stated that there is a need for not only additional studies, but also additional studies 
with a different case-mix before results can be generalized to all types of ICU settings 
and ICU patients. 
Diagnostic Efficacy 
Two studies, one level II and one level III, compared daily routine CXR with 
clinically-indicated CXR on diagnostic efficacy for patients on mechanical ventilation.  
One of these studies was randomized which increased confidence in the findings.  Both 
studies found that elimination of daily routine CXRs did not change diagnostic efficacy.  
The researcher cautioned that the samples were too small to conclude anything. 
Table 2.5 Quality Level of the Articles Measuring Diagnostic Efficacy 






















    
 
Clec’ h et al. (2008) also conducted a randomized control trial to determine if 
daily routine CXRs are useful in mechanically ventilated patients.   
191 patients were deemed eligible and the remaining 26 were excluded because of: 
length of mechanical ventilator days less than 48 hours, reintubation, therapeutic 
limitation and tracheostomy (Clec’h, et al. 2008.  After meeting the selection criteria 
165 patients were selected to participate in the study.  Eighty-four patients were 
assigned to the daily routine CXR group and 81 were assigned to the clinically-
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indicated CXR group.  As stated in a previous outcome, this study was categorized as 
a rating of level II.  Clec’h et al. (2008) aimed to compare the diagnostic efficacy of a 
clinically-indicated CXR with that of a daily routine CXR.  The diagnostic findings of 
the daily routine group revealed that most daily CXRs were not helpful with 
diagnostic efficacy.  Of 885 CXRs obtained, only 64 revealed new findings.  New 
diagnostic findings on daily routine CXRs accounted for 66% versus clinically-
indicated CXRs 7.2% (p <.0001).  In conclusion, the researcher found that clinically-
indicated CXRs in mechanically ventilated patients were associated with better 
diagnostic efficacy without impairing patient outcomes. 
Kager et al. (2010) conducted a prospective nonrandomized study.  This study 
was categorized as a level III.  The study included patients from a 28-bed mixed 
medical-surgical university-affiliated ICU setting.   
The demographics of the sample population included an average of 62 (Kager er al. 
(2010).  Further demographics of the patient population included medical patients 
(including cardiology and pulmonary disease patients), surgery patients (including 
trauma patients), orthopedic surgery and urology patients), cardiothoracic surgery 
patients, and neurology patients (including patients after neurosurgery) (Kager et al 
(2010).  Throughout the study, diagnostic efficacy of daily routine versus clinically-
indicated use of CXRs was assessed.   
Diagnostic efficacy included the number of CXRs with new or progressive 
major predefined findings divided by the total number of CXRs obtained.  Diagnostic 
efficacy was also used as an indicator of the value of the CXR to assist in 
development of a diagnosis either by the intensivist clinician or the radiologist.   
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Examples of diagnostic efficacy documented in the study included:  large atelectasis, 
large infiltrates severe pulmonary congestion, massive pleural effusion, 
pneumothorax or pneumo-mediastinum or malposition of invasive devices (Kager et 
al., 2010). 
 The findings revealed that during the 10-month period, 5067 CXRs were 
obtained in 1330 patients. Of these CXRs, 1081 were admission CXRs within 6 hours 
of admission to the ICU.  Major abnormalities were defined as: large atelectasis, large 
infiltrates severe pulmonary congestion, massive pleural effusion, pneumothorax or 
pneumo-mediastinum, and malposition of invasive devices.  Kager et al, (2010) 
showed that the majority of routinely obtained CXRs did not reveal any new 
predefined major abnormalities.  Kager et al. (2010) defined major abnormalities as 
large atelectasis (>2 lobes) 5 (0.6%), large infiltrate (>1 lobe) 10 (1.2%), severe 
pulmonary edema 18(2.1%), massive pleural effusion 11 (1.3%), pneumothorax or 
pneumomediastinum 11 (1.3%), or malposition of invasive device 70 (8.2%). Of 854 
routine CXRs, 14% or 117 CXRs demonstrated a major abnormality.    This 
researcher went on to illustrate that the incidence of potentially clinically relevant 
abnormalities on routinely obtained admission CXRs was low.   
Therapeutic Efficacy 
Two studies, one level II and one level III, compared daily routine CXR with 
clinically-indicated CXR on therapeutic efficacy for patients on mechanical 
ventilation.  All studies found that elimination of daily routine CXRs did not change 




Table 2.6 Quality Level of the Articles Measuring Therapeutic Efficacy 






















    
 
Clec ‘h et al. (2008) also presented data on the therapeutic efficacy of daily routine 
CXRs versus clinically-indicated CXRs.  This study was rated at level II.  191 
patients were deemed eligible and the remaining 26 were excluded because of: length 
of mechanical ventilator days less than 48 hours, reintubation, therapeutic limitation 
and tracheostomy (Clec’h, et al. 2008).  According to Clec’h, et al. (2008) there was 
no statistical difference with regard to age, gender, severity source, and reason for 
intubation.    After meeting the selection criteria 165 patients were selected to 
participate in the study.  Eighty-four patients were assigned to the daily routine CXR 
group and 81 were assigned to the clinically-indicated CXR group.   
Clec’h et al. (2008) aimed to compare the diagnostic efficacy of a clinically-indicated 
CXR with that of a daily routine CXR.   
 According to the study by Clec ‘h et al. (2008) of the 94 clinically-indicated 
CXRs, 53 revealed new findings important enough to prompt therapeutic 
intervention.  Therapeutic intervention included changes in the following: antibiotic 
therapy, bronchoscopy, administration or change in diuretics/ dobutamine, 
thoracentesis, and repositioning of endotracheal tube and lines.  Of the 885 CXRs 
obtained in the daily routine group, only 49 revealed a new finding important enough 
to prompt therapeutic intervention.  Therapeutic intervention statistical data for the 
daily routine CXR group included: antibiotic therapy (34), bronchoscopy (9), 
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administration or change in diuretics/ dobutamine (5), and thoracentesis (5). Clec’h et 
al. (2008).  Statistical data for the clinically-indicated group included a total of 94 
studies with 53 new findings which include:  antibiotic therapy (29), bronchoscopy 
(11), administration or change in diuretics/ dobutamine (5), and thoracentesis (4).  
Kager et al. (2010) conducted a prospective nonrandomized study.  This study 
was categorized at a rating of III.   Demographics of the sample include a total of 854 
patients.  The average age was 62 years of age, and most patients had medical, 
general surgery, cardiothoracic surgery, or neurosurgery as an admitting diagnosis 
Kager et al. (2010).  Study findings indicated that approximately one-third of 
routinely obtained admission CXRs with a new predefined major abnormality 
revealed clinically relevant information (i.e. atelectasis, infiltrate, pneumonia, pleural 
effusion, pneumothorax/ pneumomediastinum, or malpositioning of tubes or lines) 
Kager et al. (2010).  Of the 40 CXRs, 4% of all admission CXRs, 5% of all routinely 
obtained CXRs, and 34% of routinely obtained chest x-rays with a predefined major 
abnormality resulted in a change in therapy.  Kager et al. (2010) found that 
therapeutic efficacy resulted in a change in therapy very minimally out of the 854 
daily routine CXRs.  Incidence of change in therapeutic efficacy is due to:  large 
atelectasis 1(0.1%), large infiltrate 6 (0.5%), severe pulmonary congestion 2 (0.2%), 
massive pleural effusion 4 (0.5%), pneumonthorax/ pneumomediastinum 5 (0.6%), 
malposition of invasive devices 30 (3.5%), and total number of CXRs with new 
abnormalities 40 (4.7%) Kager t al. (2010).  While 40% is high, the research doesn’t 





Two studies, one level I and one level III, compared daily routine CXR with 
clinically-indicated CXR on costs of ICU patients on mechanical ventilation.  All 
studies found that elimination of daily routine CXRs did decrease costs in the ICU. 
























    
 
Oba & ZaZa (2010) highly debated use of daily routine versus clinically-indicated 
CXRs.  The study by Oba & ZaZa was rated a level I because of its high quality rating.   
A total of 7078 ICU patients were included in the analysis.  Of the 7078, patients 3429 
underwent daily routine CXRs and 3649 had the clinically-indicated CXRs.  Factors 
affecting costs included: length of days on mechanical ventilation, length of stay in the 
ICU, length of stay in the hospital, and risks of potential complications.  The 
researchers concluded that an alternative strategy such as obtaining a CXR only when 
clinically-indicated would save healthcare costs (Oba & ZaZa, 2010).  According to the 
Institute for Healthcare Improvement (2014), VAP as an estimated costs of $40,000 to a 
typical hospital stay. 
 Hendriske (2007) conducted a prospective observational study in an adult 10-bed 
mixed medical surgical ICU.  This study was rated a level III.  This study collected 
1780 daily routine CXRs.  The sample population included data on 1780 daily routine 
CXRs in 559 hospital admissions.  The study period lasted 1-year and was divided into 
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two parts.    The first part of the study focused on outcome variables such as costs.  
However the second part of the study focused on other outcome variables.  A total CXR 
volume reduction of 35% which equaled $9,900 per bed per year was documented by 
the author of this study, however the total number of beds was not revealed.  
Conversely, they found a 50% decrease in the total number of CXRs per patient per 
day.  In the study, a change of practice to clinically-indicated CXRs resulted in a 
savings of $100,000/year.   
Radiation Exposure 
Three studies, one level I, one level three, and one level IV, compared daily 
routine CXR with clinically-indicated CXR on radiation overexposure for patients on 
mechanical ventilation.  All studies found that elimination of daily routine CXRs did 
change radiation overexposure in the ICU.  


























   
 
In the meta-analysis by Oba and ZaZa (2010), the researchers sought to 
examine whether abandoning daily routine CXRs would adversely affect patient 
outcomes for missing VAP.  Oba and Zaza (2010) examined a total of eight studies 
with a total of 7078 identified patients.  The mean age for the patients was 62.8 years 
(62.5 for routine CXR group and 63.0 for the clinically-indicated group.  The author 
goes on to say that 95 % of the patients selected were medial (i.e. nonsurgical) and 
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61% of these patients were mechanically ventilated.  The authors did not include 
specific costs analysis information associated with daily routine versus clinically 
indicated CXRs.  In turn, the researchers found that elimination of daily routine 
CXRs did not adversely affect outcomes and in terms for missing VAP but did show 
a decrease in radiation exposure Oba and ZaZa (2010) went on to say that there 
should be protocols in place to promote clinically-indicated rather than daily routine 
CXRs to reduce unnecessary radiation exposures for patients and staff. 
Hendriske (2007) found a 50% decrease in the total number of CXRs per patient 
per day.  Prat (2009) submitted data on radiation exposure in a retrospective 
comparative study.  The author went on to say that although radiation exposure was 
decreased with clinically-indicated CXRs versus daily routine x-rays that the problem 
is likely multi-factorial. 
Synthesis of Findings 
Of the 15 articles reported for this evidenced-based practice project, none of 
the studies found a decrease in quality of patient outcomes when using clinically-
indicated CXRs versus daily routine CXRs for adult ICU patients on ventilators.    
The quality of the evidence is moderate and the most compelling findings show that 
instituting clinically-indicated CXR strategy would not produce adverse patient 
outcomes.   
In other words using clinically-indicated CXRs would not increase patient risk 
for complication as measured by length of stay, number of ventilator days, 
complications and mortality.  However, diagnostic efficacy and therapeutic efficacy 
are not as strongly supported in the literature.  More research needs to be done on the 
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formula in accurately representing diagnostic and therapeutic efficacy, and there 
needs to be validation to measure diagnostic and therapeutic efficacy.  Obviously, 
cost would be reduced if the number of CXRs were reduced. 
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Discussion of Potential Barriers/ Supports for 
Adoption of Practice Innovation/ Best Practice 
 Upon review of the literature the author of this evidenced-based practice project 
has identified potential barriers and or supports for adoption of practice innovation for 
best practice.  A readiness assessment was not completed but the barriers identified 
here included the author’s foresight of various healthcare disciplines within the acute 
care setting.   
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These barriers for adoption of practice innovation included provider resistance to 
change as a daily CXR is routine and engrained into their current practice.  Another 
barrier is staffing.  Various healthcare disciplines including both nursing and  
respiratory therapies assumption that although a daily CXR is not ordered by the 
clinician the staff is also resistant to change and will order the CXR as they assume that 
provider would have wanted the diagnostic test.  Although there is evidence to change 
to clinically-indicated CXRs intensivist providers may still be resistant to change 
current practice. 
Support for adoption of practice innovation for best practice includes the effect on 
patient safety as unnecessary test are not performed for those who may not need it, 
and also the cost effectiveness for not obtaining an unnecessary diagnostic test.  
Changing practice protocol to clinically-indicated CXRs seems promising.  Before 
making this recommendation to ICU staff, the author will do a chart audit of patients 
in an ICU to determine if those outcomes are supported by the evidence.  Outcomes 
include:  ICU length of stay, complications while on the ventilator and ICU mortality, 
number of ventilator days, diagnostic efficacy, therapeutic efficacy, costs, and 
radiation exposure.  Chapter III contains the description of the chart audit and the data 




CHAPTER III - METHODS 
In order to gather more evidence, the author conducted a chart audit of 
mechanically ventilated patients in ICU practice population to determine if there were 
any differences in the outcome variables when comparing daily routine to clinically-
indicated CXRs.  The author also aimed to determine if these differences in the 
outcome variables affected the prevention of VAP. These outcomes include:  ICU 
length of stay, complications while on the ventilator and ICU mortality, number of 
ventilator days, diagnostic efficacy, therapeutic efficacy, costs, and radiation 
exposure.    
Design 
 A descriptive study was used to collect and, improve data outcomes.  The 
population includes medical and cardiovascular ICU patients from a level III trauma 
facility.  More specifically, the descriptive study was done in the form of a 
retrospective chart audit.   Pending IRB approval from the organization and the 
university the chart audit will commence September 1, 2014, with retrospective chart 
review.     
Participants and Setting 
 Medical records of patients with respiratory pathology on ventilators in the ICU 
will be reviewed.  Charts were reviewed for 30 patients with daily routine CXRs and 
30 patients who have had clinically-indicated CXRs for a total of 60 patients at a 
North Carolina medical center. 
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 Patients with respiratory pathophysiology criteria inclusion are selected in order to 
compare patients with similar diagnosis.  These patients are also the ones most likely 
to have ventilator complications such as VAP.   
Instruments 
 The author developed a chart audit tool based on the outcomes identified in the 
analysis of research findings in Chapter II. The chart audit tool is divided into eleven 
sections.  Section one focuses on subject demographic information.  Demographic 
information includes subject numbers, gender, age, and race.  No identifiers will be 
linked to the patient’s name or chart number, or medical record.  The second section 
focused on the subject date of admission, and whether or not the patient was intubated 
on admission.  The third section identified the respiratory pathology for the 
participant on admission.  The fourth section reviewed ICU length of stay.  Fifth, the 
audit tool focused on complications and mortality while on the ventilator in ICU.  
Sixth, the number of ICU ventilator days was documented.  Seventh, diagnostic 
efficacy was reviewed.  Eighth, therapeutic efficacy was obtained.  Ninth, cost 
associated with the number of CXRs was identified.  Tenth, the opportunity for 
radiation overexposure was identified.  The final section includes the type of strategy 
used for the CXR, either daily routine or clinically-indicated.   
Procedure 
 The author collaborated with the Informatics Manager and Informatics Analyst 
at the institution to identify electronic patient records that met the requirements of the 
chart audit.  After the selected electronic charts were provided from the Informatics 
Analyst, the author initiated and completed the data collection process.   
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The author obtained Institutional Review Board (IRB) approval from USC and 
the regional medical center to conduct the electronic chart review.   
The author also worked with the Informatics Manager at her facility to generate a list 
of patients in the medical ICU that fit the inclusion sample criteria.   
The data collected was placed on a secure and encrypted flash drive that was 
password protected.  The password was only known by the author.  Next, the author 
requested a total of 40 charts per day to review during each 8 hour chart audit day.  
No protected health information was removed from or transferred from the 
organizations electronic records.  The author selected one chart at a time to review 
and data was extracted to complete according to the audit tool criteria.  Next, the 
information was tracked electronically via the same secure and encrypted flash drive.  
The data collected was then placed into an excel spreadsheet created by the author.  
The excel spreadsheet was also maintained only by the author via a secure and 
encrypted flash drive.  The chart audit began with ICU patients starting June 1, 2014 
and ending August 31, 2014.  No patient identifiers were collected except race, age, 
and gender. 
 The author collected, extracted, and trended data via the excel spreadsheet.  The 
author continued to retrospectively collect data until there are 30 patients with daily 
routine CXRs and 30 patients with clinically-indicated CXRs for a total of 60 patients 






Protection of Human Subject Health Information 
IRB approval was obtained from USC and CaroMont Regional Medical Center.  This 
project is a quality improvement evidenced-based practice project and; therefore, 
organization IRB approval was expedited.  Confidential patient health information 
was protected by collecting data electronically using a secure flash drive and auditing 
each chart individually and closing out charts immediately after data was collected.  
There were no patient identifiers on the chart audit tool.  Patient names or 
identification numbers were never associated with data to the patients’ electronic 
medical record.  USC IRB committee approval was also expedited as this is 
retrospective chart audit evidenced-based practice project.   
To ensure human subject protection, the CITI Certification (an ethical training 
program facilitator) was completed by the author (See Appendix C).  As previously 
stated this evidenced-based practice project will be a retrospective chart audit method 
design.  With use of this methodology therefore there was minimal to no harm to 
project participants.   
Prior to undergoing the project, an approval to initiate the project was sought 
from the Institutional Review Board (IRB) at University of South Carolina.  
Furthermore, an approved IRB board was utilized prior to undergoing the project 
within the approved acute care facility at CaroMont Regional Medical Center.  The 
IRB board reviewed the application and made a determination regarding the 
application.  A compliance officer in the office of sponsored programs emailed to the 
author the approval and exempt status and gave permission to proceed with the 
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quality improvement project.  A copy of the CITI training can be found in Appendix 
C. 
Data Analysis 
After a total of 60 patients are audited that met the authors criteria for this 
evidenced based-practice project the data were analyzed via a statistical analysis 
system (SAS 9.4).  The author took the chart audit tool and created an Excel 
spreadsheet that included the demographic information, outcome, and CXR variables.  
The demographic variables were analyzed using measures of central tendency.  
Descriptive statistics were calculated on the selected variables.  Frequency 
distribution was used to describe for categorical variables. Continuous variables 
statistics included measure of central tendency (mean and median) and measure of 
spread (standard deviation and range). The descriptive statistics for main variables 
were conducted by group. 
Simple inferential statistics were used to analyze the differences between 
groups by outcomes.  The statistical procedures were based on the level of data.  










Table 3.1 Data Analysis 








Number of Complication 
Mortality: Yes/No 
1-way Anova  
CHI Square Analysis 
Number of Days of 
Ventilation 
Number of Days 1-way Anova 
Diagnostic Efficacy Number of Complication 
Divided By Number of 
Days in ICU 
Two-Sample Proportion 
Test 
Therapeutic Efficacy Number of Interventions 1-way Anova 
Cost Cost Facility Charges Per 
CXR 
1-way Anova 
Radiation Number of CXRs 1-way Anova 
 
Summary 
The evidenced based-practice project question was answered using a descriptive 
study with a chart audit tool.  IRB approval from the data collection site and the 
academic institution were both obtained.  Chapter 4 of this evidenced-based practice 
project will describe the findings of data collection.  
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CHAPTER IV - RESULTS 
INTRODUCTION 
 The purpose of this project was to determine if there were any differences in 
patient outcomes with ICU patients on ventilators in the prevention of VAP between 
those who received daily routine CXRs and those who received clinically-indicated 
CXRs.  The patient outcomes measured were ICU length of stay, complications while 
on the ventilator, ICU mortality, number of ventilator days, costs, and radiation 
exposure?  Chapter 2 indicated that there were no differences in patient outcomes 
with VAP but there was significant financial costs savings with clinically-indicated 
CXRs.  A retrospective chart audit of patients in the authors’ practice site was 
conducted to see if those patient outcomes matched the literature findings.  Chapter 
IV provides an analysis of the results from the evidenced-based practice project.  
Chapter IV is divided into the following sections: description of the sample, analysis 
of the evidenced-based practice question, additional analysis, and summary. 
Description of Sample 
 The population of records from which the sample was drawn was generated by a 
regional hospitals informatics analyst.  The hospital analyst, using the chart audit tool 
as a guide, generated a list of 234 patients admitted to the medical ICU from April 1, 
2014 to September 1, 2014.  The author began by examining the electronic charts in 





The sample consisted of 60 records of patients who had been admitted and discharged 
from an 8-bed medical ICU in a North Carolina regional hospital.  All of the patients 
were on ventilators.  The sample was evenly divided between male (30) and females 
(30). The mean age the sample was 59.3 with a SD (Standard Deviation) of 16.6.  The 
ethnicity in the sample consisted of 54 Caucasian, 5 African American, and 1 other.   
The most common reasons for admission to the ICU were:  ventilator 
dependent respiratory failure, sepsis, and chronic obstruction pulmonary disease 
exacerbation.  The mean number of days in the ICU was 4.5with a SD of 0.8.  The 
mean number of days on the ventilator in the ICU was 4.7 with a SD of 1.6.  Data 
were collected from records of patients hospitalized between June 1, 2014 and August 
31, 2014.  There were a total of 10 ICU deaths for patients on the ventilator for the 
duration of this data collection timeframe.  The remaining 50 patients transferred 
either to the post-intensive care unit, another monitored bed unit, or the medical floor. 
Analysis of the Evidenced-Based Practice Question 
 Following the review of the 60 records the author discovered that CXRs for 
only one patient used the clinically-indicated method.  The authors choose to stop 
data collection because it was clear that the current practice is for all ventilated 
patients to receive a daily CXR.  If only one patient per every three months is ordered 
to get clinically-indicated CXRs the author would have to go back 20 months or 
almost two years to have any chance of accruing a clinically-indicated CXR group.  
The danger in this approach is that the patients would not be homogenous.  Policy 
changes, practice changes, equipment changes, personnel changes, and disease 
prevalence patterns would make the threat of history inevitable.  While the failure to 




The current accepted practice in the medical ICU does not conform to findings 
in the literature.  This practice pattern is understandable because the following: fear of 
missing a potential patient complication, fear of a malpractice suit, profit benefit, cost 
of doing multiple CXRs, tradition, and clinician comfort levels.  The challenge for 
medical ICU providers is to find a balance between excessive costs, radiation 
overexposure, and patient safety versus provider comfort.   
Summary 
 In the critical care setting the need for diagnostic imaging plays a crucial role in 
the assessment, and appropriate management of the ICU patient on a ventilator.   The 
chart audit revealed that only one patient was treated using the clinically-indicated 
CXR approach.  Therefore, there needs to be an ongoing discussion regarding the use 
of daily routine versus clinically-indicated CXRs for patients on ventilators as new 
knowledge is developed.  Chapter five presents recommendations for clinical 
practice, policy development, research and education.  
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CHAPTER V - DISCUSSION 
INTRODUCTION 
The purpose of this project was to determine if there were any differences in 
patient outcomes with ICU patients on ventilators in the prevention of VAP between 
those who received daily routine CXRs and those who received clinically-indicated 
CXRs.  The evidence-based practice question is: In the adult ICU patient on the 
ventilator, is there a difference between daily routine CXRs and clinically-indicated 
CXRs on patient outcomes of ICU length of stay, complications while on the 
ventilator, ICU mortality, number of ventilator days, costs, and radiation exposure?  
A retrospective chart audit of 60 patients on ventilators in the medical ICU was 
conducted.  Only one patient was managed with clinically-indicated CXRs, making it 
impossible to compare the two groups.  Chapter V presents recommendations and 
implications for practice, policy development, research and education.     
Recommendations for Practice 
There is evidence supporting the use of clinically-indicated CXRs for patients 
on ventilators in the ICU.  The practice pattern in the medical ICU at the regional 
healthcare system did not match the current literature findings.  The author reported 
findings of the retrospective chart audit to the medical ICU director who expressed 
support for decreasing the number of CXRs that patients on ventilators receive.  
Members of the intensivist staff were supportive in the reduction of the number of 
CXRs patients on ventilators receive. 
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Intensivist colleagues were supportive as well in the development of a practice 
algorithm. The author has determined that there is a need for practice protocol 
development for daily routine versus clinically-indicated CXRs.  In addition there 
needs to be an ongoing discussion among critical care providers regarding the need 
for this change in practice.   
Recommendation 1:  There is currently enough evidence to change clinical practice. 
Recommendation 2:  Develop an ongoing dialogue among the professional staff 
concerning evidence for CXR use.   
Recommendation 3:  Collect literature regarding indicators for the signs and 
symptoms of CXRs for patients on ventilators. 
Recommendation 4:  Develop an algorithm. 
Recommendation for Policy Development 
Currently the medical ICU has no policy on daily routine versus clinically-
indicated CXRs for patients on the ventilator.   
Recommendation 1:  Develop a policy. 
Recommendation for Research 
 It is possible to have quasi- experimental studies comparing patient outcomes 
between these two methods of care.   
Recommendation 1:  Conduct more quasi-experimental studies comparing two 
methods of care. 





Recommendation for Education 
Sensitizing the staff to the pros and cons of daily routine CXRs is important.  
Nursing and radiology staff would need to be included in the process development for 
identifying indicators for CXR use.   
It is important to keep the conversation going between physicians, nurse practitioners, 
nurses, radiologist, and other staff members so that a transition towards clinically-
indicated CXRs may be proposed. 
Recommendation 1:  Present findings of the evidenced-based practice project to the 
staff. 
Recommendation 2:  Involve staff members in the development of clinical indicators 
for the algorithm. 
Summary 
 The author has identified that there needs to be ongoing discussion regarding the 
use of daily routine versus clinically-indicated CXRs for patients on ventilators.  The 
main limitation for this quality improvement project included identifying only a small 
number of patients in the authors practice site that receive clinically-indicated CXRs.  
Therefore, the evidenced-based practice question is currently unable to be answered.  
The analysis of the literature revealed that there is no advantage to daily routine CXRs 
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